Name:

Burkholderia diffusa Vanlaere et al. 2008

DSM No.:

23434, Type strain

Strain designation:

AU1075, O85

Other collection no.

or WDCM no.:

CCUG 54558, LMG 24065

Isolated from:

sputum of patient with cystic fibrosis

Country:

United States of America

Date of sampling:

before 15.03.2010

Nagoya Protocol Restrictions:

There are NO known Nagoya Protocol restrictions for this strain.

History:

<- CCUG <- E. Vanlaere, LMG <- J. J. LiPuma

Genbank accession numbers:

16S rRNA gene: AM747629

Cultivation conditions:

Medium 535 , 30°C

or

Medium 693 , 30°C

Complete DSMZ Media List

Summary and

additional information:

<- CCUG <- E. Vanlaere, LMG <- J. J. LiPuma. Sputum of patient with cystic fibrosis; USA. Type strain. Sequence accession no. 16S rRNA gene: AM747629. (Medium 535 or Medium 693, 30°C).

For detailed information:

Risk group:

2 (classification according to German TRBA)

Restrictions:

Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1

Supplied as:

Delivery form Prices

Price Category for this culture: 1

Freight and handling charges will be added. See price list.

Note: Freight charges for Risk Group 2 microorganisms will apply.

Other cultures:

All DSMZ cultures of the species

Print data sheet

Add to CartOpen Pricelist

Help Topics

FAQOrder & DeliverySafetyQuality assurance

Phenotypic information about Burkholderia diffusa DSM 23434

Nomenclatural information about Burkholderia diffusa